Michal Krauze
Medical Oncology Physician · Pittsburgh, PA
Michal Krauze is a medical oncology physician with a practice address in Pittsburgh, Pennsylvania, and NPI 1033344213, issued on May 18, 2009. Check the license (Pennsylvania MD438669, as entered in NPPES) on the Pennsylvania Department of State (PALS); the Medicare figures below come from public CMS files.
- Name
- Michal Krauze
- Primary taxonomy
- Medical Oncology Physician 207RX0202X
- License number
- MD438669 PA
Self-reported in NPPES; status is on the state search - Practice location
- 1400 Locust St Ste G103, Pittsburgh, PA 15219
- Phone
- (412) 496-1717
- Enumerated
- May 18, 2009
- Record last updated
- Oct 29, 2021 (not updated in 5 years: call before relying on the address or phone)
- Medicare enrollment
- Enrolled (PECOS I20120727000127); accepts Medicare assignment
- Entity
- Type 1 · individual
8 nearest medical oncology physician records → All 265 in Pennsylvania → Look up another NPI →
Also registered at 1400 Locust St Ste G103
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Kelsey Dilks, PA-CMedical Physician Assistant1720853740
- Darcie IlgMedical Physician Assistant1245787803
Verify Michal Krauze in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersPennsylvania Department of State (PALS)
Search for license MD438669Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
11% fewer Medicare Part D claims than the average medical oncology physician in 2024
623 Medicare Part D claims for 120 beneficiaries, against an average of 703 among the 4,230 providers of this specialty who prescribed in Part D. Brand-name drugs were 37% of claims.
Most prescribed
- Hydroxyurea65 claims
- Prednisone48 claims
- Ondansetron Hcl41 claims
- Erleada33 claims
- Eliquis32 claims
- Xarelto27 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $17.02
1 payment: education; the largest payer was Regeneron Healthcare Solutions, Inc. The 3,343 providers of this specialty with any payment received $11,773.47 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through one group practice
- Hematology Oncology AssociationGreensburg, PA
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Michal Krauze among 265 medical oncology physician records in Pennsylvania
Michal Krauze is one of 265 medical oncology physician records with a practice address in Pennsylvania. 83% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2009, is newer than 69% of them.
- NPI issued2009 · 69% of these records are older, 27% newer
- In a Medicare fileYes · 83% of these records are
- In the CMS Doctors and Clinicians fileYes · 71% of these records are
- Graduated2003 · median 2002 among the 189 with a school on file
- Record last updated2021 · 68% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RX0202X and a Pennsylvania practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Medical Oncology Physician providers in Pennsylvania
There are 265 medical oncology physician records in Pennsylvania.
All 265 in Pennsylvania → Every provider in Pittsburgh → Medical Oncology Physician nationwide →
The 8 medical oncology physician records with the nearest ZIP codes
- Raisa Silva, MDPittsburgh, PA 152241669095832
- Nancy Davidson, M.D.Pittsburgh, PA 152131114954153
- Shannon Huggins-Puhalla, MDPittsburgh, PA 152131326251299
- Ashwin SomasundaramPittsburgh, PA 152131356784763
- Antonios Christou, M.D.Pittsburgh, PA 152121922044098
- Larisa Greenberg, MDPittsburgh, PA 152121144220385
- Ariel Lopez-Chavez, M.D., M.S.Pittsburgh, PA 152121871786913
- Dulabh Monga, MDPittsburgh, PA 152121578564019
Common questions
What is Michal Krauze's NPI number?
Michal Krauze's National Provider Identifier (NPI) is 1033344213, issued on May 18, 2009. An NPI identifies a provider in billing; it is not a license.
Where is Michal Krauze located?
The NPPES record lists a practice address at 1400 Locust St Ste G103, Pittsburgh, PA, 15219. Phone: (412) 496-1717. Providers update this record themselves, so call before visiting.
How can I verify Michal Krauze's license?
NPPES lists Pennsylvania license number MD438669, as entered by the provider. Search the Pennsylvania Department of State (PALS) at https://www.pals.pa.gov/. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Michal Krauze prescribe under Medicare Part D?
In 2024, Michal Krauze had 623 Medicare Part D claims for 120 beneficiaries; the average among medical oncology physician prescribers was 703. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.